The current state of precision medicine in long-term and post-acute care, and potential future advancements, are discussed with Dr Joel Diamond, CMO of Aranscia.
The current state of precision medicine in long-term and post-acute care, and potential future advancements, are discussed with Dr Joel Diamond, CMO of Aranscia.
The current state of precision...